Pregnancy: Category C.
There are no data from the use of pegfilgrastim in pregnant women. Studies in animals have shown reproductive toxicity. The potential risk to the human embryo or foetus is unknown. Pegfilgrastim should not be used during pregnancy unless clearly necessary.
Lactation: Not known whether pegfilgrastim is distributed into milk, therefore pegfilgrastim should not be administered in lactating women.
Other Services
Country
Account